MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
Diabetes Obes Metab. 2021 Mar;23(3):730-741. doi: 10.1111/dom.14278. Epub 2020 Dec 21.
Short-term weight loss may lead to remission of type 2 diabetes but the effect of maintained weight loss on cardiovascular disease (CVD) is unknown. We quantified the associations between changes in weight 5 years following a diagnosis of diabetes, and incident CVD events and mortality up to 10 years after diagnosis.
Observational analysis of the ADDITION-Europe trial of 2730 adults with screen-detected type 2 diabetes from the UK, Denmark and the Netherlands. We defined weight change based on the maintenance at 5 years of weight loss achieved during the year after diabetes diagnosis, and as 5-year overall change in weight. Incident CVD events (n = 229) and all-cause mortality (n = 225) from 5 to 10 years follow-up were ascertained from medical records.
Gaining >2% weight during the year after diabetes diagnosis was associated with higher hazard of all-cause mortality versus maintaining weight [hazard ratio (95% confidence interval): 3.18 (1.30-7.82)]. Losing ≥5% weight 1 year after diagnosis was also associated with mortality, whether or not weight loss was maintained at 5 years: 2.47 (0.99-6.21) and 2.72 (1.17-6.30), respectively. Losing ≥10% weight over 5 years was associated with mortality among those with body mass index <30 kg/m [4.62 (1.87-11.42)]. Associations with CVD incidence were inconclusive.
Both weight loss and weight gain after screen-detected diabetes diagnosis were associated with higher mortality, but not CVD events, particularly among participants without obesity. The clinical implications of weight loss following a diagnosis of diabetes probably depend on its magnitude and timing, and may differ by body mass index status. Personalization of weight loss advice and support may be warranted.
短期体重减轻可能导致 2 型糖尿病缓解,但维持体重减轻对心血管疾病(CVD)的影响尚不清楚。我们量化了糖尿病诊断后 5 年内体重变化与 CVD 事件和诊断后 10 年内死亡的相关性。
对英国、丹麦和荷兰的 2730 名经屏幕检测出的 2 型糖尿病患者进行了 ADDITION-Europe 试验的观察性分析。我们根据糖尿病诊断后一年内维持的体重减轻量和 5 年内体重的总体变化来定义体重变化。从医疗记录中确定 5 至 10 年随访期间的 CVD 事件(n = 229)和全因死亡率(n = 225)。
糖尿病诊断后一年内体重增加>2%与全因死亡率升高相关,与维持体重相比,风险比(95%置信区间)为 3.18(1.30-7.82)。诊断后 1 年体重减轻≥5%也与死亡率相关,无论 5 年后体重是否减轻:分别为 2.47(0.99-6.21)和 2.72(1.17-6.30)。5 年内体重减轻≥10%与 BMI<30kg/m2 的患者的死亡率相关[4.62(1.87-11.42)]。与 CVD 发病率相关的结果尚无定论。
糖尿病诊断后体重减轻和增加均与死亡率升高相关,但与 CVD 事件无关,尤其是在没有肥胖的患者中。糖尿病诊断后体重减轻的临床意义可能取决于其幅度和时间,并且可能因 BMI 状况而异。可能需要个性化的体重减轻建议和支持。